# Scilex Pharmaceuticals Inc. – FDA Inspection, May 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/scilex-pharmaceuticals-inc/d7d1ad6c-655c-4bae-bcb9-2ed432935fa4
Source feed: FDA_Inspections

> FDA inspection 1318960 of Scilex Pharmaceuticals Inc., May 20, 2026. 1 citation under 21 CFR part 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1318960
- Company Name: Scilex Pharmaceuticals Inc.
- Inspection Date: 2026-05-20
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/scilex-pharmaceuticals-inc/de4ca2fe-59db-4bc6-bf04-c3a4d7db1987

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df